Latest Breaking News On - Hannah balfour - Page 8 : comparemela.com
EMA’s transformative treatments of 2020
1
In this article, we summarise the trial findings for the European Medicines Agency’s 13 most transformative therapies of 2020.
Despite the challenges presented by COVID-19, 2020 was a bumper year for approvals by the European Medicines Agency (EMA). According to their latest report, the EMA recommended a total of 97 human medications for approval in 2020, including 22 orphan drugs and 39 new active substances.
In this article,
European Pharmaceutical Review’s Hannah Balfour summarises the trial findings for the treatments reported to significantly advance their therapeutic areas during 2020.
The EMA’s Human Medicines Highlights 2020 report lists all the medicines recommended for approval in 2020 by their indications. Overall, oncology had the most approvals – 21 in total – followed by haematology/haemostaseology with 14 and infectious diseases and pneumology/allergology, each with 11. Oncology also had the largest number of
United-states
Congo
Enerzair-breezhaler
Zimbus-breezhaler
Hannah-balfour
European-medicines-agency
Committee-for-medicinal-products-human-use
European-pharmaceutical-review
Medicines-highlights
Medicinal-products
Human-use
Democratic-republic
COVID-19 vaccines: how important is the vial?
8
In this article we discuss how the problems associated with glass vial packaging may disrupt COVID-19 vaccine distribution and explore some of the latest innovations to overcome it.
The glass vials into which vaccines and most other biologic drugs are packaged have changed very little in the past 100 years. Traditional borosilicate glass vials have several safety concerns associated with them, from the possibility of breakages to their potential to delaminate. To find out how these issues affect pharma and their possible impact on COVID-19 vaccine distribution,
European Pharmaceutical Review’s Hannah Balfour spoke with Lawrence Ganti, Chief Business Officer of SiO2, an innovative materials science company who has developed hybrid vials for biologics.
China
Germany
United-states
India
America
German
Hoffk-corning
Lawrence-ganti
Hannah-balfour
Friedrich-otto-schott
Pfizer
Drug-administration